Samrat Pharmachem Limited (BOM:530125)

Samrat Pharmachem Revenue

In the fiscal year ending March 31, 2025, Samrat Pharmachem had annual revenue of 2.86B INR with 1.50% growth. Samrat Pharmachem had revenue of 712.03M in the quarter ending March 31, 2025, a decrease of -13.94%.

• Revenue: 2.86B
• Revenue Growth: +1.50%
• P/S Ratio: 0.40
• Revenue / Employee: 89.33M
• Employees: 32
• Market Cap: 1.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.86B	42.22M	1.50%
Mar 31, 2024	2.82B	-291.06M	-9.37%
Mar 31, 2023	3.11B	888.86M	40.06%
Mar 31, 2022	2.22B	426.92M	23.83%
Mar 31, 2021	1.79B	416.39M	30.28%